Nautilus Biotechnology, Inc.

NasdaqCM:NAUT Stock Report

Market Cap: US$330.4m

Nautilus Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:NAUT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Mar 26BuyUS$65,238Sujal PatelIndividual25,000US$2.61
06 Nov 25BuyUS$5,960Ken SuzukiIndividual4,000US$1.49
08 Sep 25BuyUS$135,575Sujal PatelIndividual200,000US$0.68
04 Sep 25BuyUS$12,858Matthew MurphyIndividual20,000US$0.64

Insider Trading Volume

Insider Buying: NAUT insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NAUT?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,457,0551.15%
Institutions22,744,22717.9%
General Public24,473,86519.3%
VC/PE Firms37,421,11329.4%
Individual Insiders40,982,59532.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.3%
Parag Mallick
20,693,392US$53.8m0%no data
13.9%
Andreessen Horowitz LLC
17,653,917US$45.9m0%2.83%
13.7%
Sujal Patel
17,461,232US$45.4m0%no data
9.91%
Perceptive Advisors LLC
12,594,211US$32.7m0%0.64%
5.64%
Cercano Management LLC
7,172,985US$18.6m0%0.71%
4.74%
Madrona Venture Group
6,020,770US$15.7m0%67.79%
2%
Vanguard Capital Management, LLC
2,545,597US$6.6m0%no data
1.83%
Clearstead Advisors, LLC
2,329,784US$6.1m0%0.06%
1.74%
Comprehensive Financial Management LLC
2,207,619US$5.7m0%0.18%
1.49%
Farzad Nazem
1,888,146US$4.9m0%no data
1.15%
Amazon.com, Inc.
1,457,055US$3.8m0%0.08%
1%
Millennium Management LLC
1,273,383US$3.3m24.8%no data
0.95%
The Clarius Group, LLC
1,209,646US$3.1m0%0.17%
0.59%
Sentinel Trust Co LBA
750,000US$1.9m0%0.17%
0.58%
Acadian Asset Management LLC
741,246US$1.9m21.1%no data
0.57%
Tikvah Management LLC
726,895US$1.9m0%0.51%
0.47%
Geode Capital Management, LLC
603,524US$1.6m7.6%no data
0.36%
Matthew McIlwain
459,075US$1.2m0%no data
0.29%
The Goldman Sachs Group, Inc.
363,390US$944.8k61%no data
0.26%
Dimensional Fund Advisors LP
329,123US$855.7k15.3%no data
0.25%
Marshall Wace LLP
319,882US$831.7k173%no data
0.24%
Vanguard Fiduciary Trust Company
305,526US$794.4k0%no data
0.21%
Renaissance Technologies LLC
265,700US$690.8k2.23%no data
0.17%
State Street Global Advisors, Inc.
216,270US$562.3k7.46%no data
0.16%
The Hillman Company
200,000US$520.0k0%0.18%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/29 21:40
End of Day Share Price 2026/05/29 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nautilus Biotechnology, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew SykesGoldman Sachs
Subhalaxmi NambiGuggenheim Securities, LLC
Daniel BrennanTD Cowen